Trials / Unknown
UnknownNCT02307344
Effect of Nigella Sativa on Nonalcoholic Steatohepatitis and Steatosis
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Hillel Yaffe Medical Center · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The investigators hypothesize that Nigella Sativa will have an effect on Nonalcoholic Steatohepatitis and Liver Steatosis by enhancing lipophagy in the liver tissue.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Nigella Sativa | |
| DIETARY_SUPPLEMENT | Placebo | Capsules that contain a placebo but look like the Nigella Sativa capsules |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2017-01-01
- Completion
- 2017-01-01
- First posted
- 2014-12-04
- Last updated
- 2014-12-04
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT02307344. Inclusion in this directory is not an endorsement.